Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity
- 8 October 2017
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 37 (2) , 307-314
Abstract
The purpose of this study is to examine the patient-reported outcomes (PRO) after discontinuing nonsteroidal anti-inflammatory drugs (NSAIDs) and clinical factors associated with a favorable outcome in patients with rheumatoid arthritis (RA) in remission or with low-disease activity (LDA). A 16-week prospective open-label trial was conducted at eight rheumatology clinics in Korea. RA patients with 28-joint disease activity score based on erythrocyte sedimentation rate (DAS28-ESR) < 3.2 who were on NSAIDs for more than a month were enrolled, and NSAIDs were discontinued. Acetaminophen (AAP) was used as the rescue medication, and NSAIDs were restarted when joint pain was intolerable with AAP. The endpoint was to analyze the group of patients who continued to withdraw NSAIDs. Among 109 enrolled patients, 105 completed the 16-week follow-up. Eighty-nine (84.8%) patients remained without restarting NSAIDs. In these patients, there was a slight increase in their pain levels compared with baseline (median 14.0 versus 19.0 using the pain-visual analog scale, p = 0.010). However, changes in DAS28-ESR (p = 0.638) and routine assessment of patient index data 3 (RAPID-3) (p = 0.128) were insignificant. Moreover, 66 (62.9%) patients showed sustained effectiveness on PRO without restarting NSAIDs. In the multivariate regression models, joint swelling was the detrimental factor in NSAID withdrawal (odds ratio [OR] 0.149, 95% confidence interval [CI] 0.033–0.680, p = 0.014) and sustained effectiveness (OR 0.284, 95% CI 0.091–0.883, p = 0.030). Joint pain in RA patients in remission or with LDA can be well managed without NSAIDs, especially in those without swollen joints at the time of cessation.Keywords
Funding Information
- Ministry of Health and Welfare (HI10C2020, HI14C1277)
This publication has 25 references indexed in Scilit:
- Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanismAnnals of the Rheumatic Diseases, 2016
- Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practiceArthritis Care & Research, 2012
- Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e InitiativeRheumatology, 2012
- Nonsteroidal Antiinflammatory Drug Withdrawal in Patients with Stable Rheumatoid ArthritisThe Journal of Rheumatology, 2011
- Rheumatoid arthritisThe Lancet, 2010
- A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.2010
- Patient Barriers to Pain Management May Contribute to Poor Pain Control in Rheumatoid ArthritisThe Journal of Pain, 2009
- Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: Pain has highest priorityArthritis Care & Research, 2002
- A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.2002
- Radiographic grading of the severity of knee osteoarthritis: Relation of the kellgren and lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degenerationArthritis & Rheumatism, 1991